Persistent signaling by dysregulated thrombin receptor trafficking promotes breast carcinoma cell invasion

被引:86
作者
Booden, MA
Eckert, LB
Der, CJ [1 ]
Trejo, J
机构
[1] Univ N Carolina, Lineberger Comprehens Canc Ctr, Dept Pharmacol, Chapel Hill, NC 27599 USA
[2] Univ N Carolina, Cardiovasc Biol Ctr, Dept Pharmacol, Chapel Hill, NC 27599 USA
关键词
D O I
10.1128/MCB.24.5.1990-1999.2004
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Increased expression of protease-activated receptor 1 (PAR1), a G protein-coupled receptor for thrombin, has previously been correlated with breast carcinoma cell invasion. PAR1 is irreversibly proteolytically activated, internalized, and sorted directly to lysosomes, a critical process for the termination of signaling. We determined that activated PAR1 trafficking is severely altered in metastatic breast carcinoma cells but not in nonmetastatic or normal breast epithelial cells. Consequently, the proteolytically activated receptor is not sorted to lysosomes and degraded. Altered trafficking of proteolytically activated PAR1 caused sustained activation of phosphoinositide hydrolysis and extracellular signal-regulated kinase signaling, even after thrombin withdrawal, and enhanced cellular invasion. Thus, our results reveal that a novel alteration in trafficking of activated PAR1 causes persistent signaling and, in addition to other processes and proteins, contributes to breast carcinoma cell invasion.
引用
收藏
页码:1990 / 1999
页数:10
相关论文
共 39 条
  • [1] ALBINI A, 1987, CANCER RES, V47, P3239
  • [2] INDUCTION OF MEMBRANE RUFFLING AND FLUID-PHASE PINOCYTOSIS IN QUIESCENT FIBROBLASTS BY RAS PROTEINS
    BARSAGI, D
    FERAMISCO, JR
    [J]. SCIENCE, 1986, 233 (4768) : 1061 - 1068
  • [3] Putting tumours in context
    Bissell, MJ
    Radisky, D
    [J]. NATURE REVIEWS CANCER, 2001, 1 (01) : 46 - 54
  • [4] The Rab5 effector EEA1 is a core component of endosome docking
    Christoforidis, S
    McBride, HM
    Burgoyne, RD
    Zerial, M
    [J]. NATURE, 1999, 397 (6720) : 621 - 625
  • [5] ABERRANT FUNCTION OF THE RAS SIGNAL-TRANSDUCTION PATHWAY IN HUMAN BREAST-CANCER
    CLARK, GJ
    DER, CJ
    [J]. BREAST CANCER RESEARCH AND TREATMENT, 1995, 35 (01) : 133 - 144
  • [6] Thrombin signalling and protease-activated receptors
    Coughlin, SR
    [J]. NATURE, 2000, 407 (6801) : 258 - 264
  • [7] VASCULAR-PERMEABILITY FACTOR, FIBRIN, AND THE PATHOGENESIS OF TUMOR STROMA FORMATION
    DVORAK, HF
    NAGY, JA
    BERSE, B
    BROWN, LF
    YEO, KT
    YEO, TK
    DVORAK, AM
    VANDEWATER, L
    SIOUSSAT, TM
    SENGER, DR
    [J]. ANNALS OF THE NEW YORK ACADEMY OF SCIENCES, 1992, 667 : 101 - 111
  • [8] Human breast cancer cells generated by oncogenic transformation of primary mammary epithelial cells
    Elenbaas, B
    Spirio, L
    Koerner, F
    Fleming, MD
    Zimonjic, DB
    Donaher, JL
    Popescu, NC
    Hahn, WC
    Weinberg, RA
    [J]. GENES & DEVELOPMENT, 2001, 15 (01) : 50 - 65
  • [9] ESUMI N, 1991, CANCER RES, V51, P4549
  • [10] Thrombin receptor overexpression in malignant and physiological invasion processes
    Even-Ram, S
    Uziely, B
    Cohen, P
    Grisaru-Granovsky, S
    Maoz, M
    Ginzburg, Y
    Reich, R
    Vlodavsky, I
    Bar-Shavit, R
    [J]. NATURE MEDICINE, 1998, 4 (08) : 909 - 914